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iGluR complexes are tetramers of subunits that possess three true 
transmembrane domains (TMDs A to C) and a pore loop between 
TMDs A and B that does not traverse the membrane. Receptors are 
tetrameric complexes with the subunit stoichiometry depending on 
the subfamily: while some AMPAR subunits are capable of forming 
homomeric as well as heteromeric receptors that are functional 
when expressed heterologously, NMDARs are imperatively hetero-
meric (McBain and Mayer, 1994; Wenthold et al., 1996).
The domain composition of iGluRs is modular and strictly 
conserved among the four subfamilies. For nearly all domains, 
homologies to other proteins have been found (Figure 1A). The 
extracellular portion of the protein consists of the N-terminal 
domain (NTD) and the ligand binding domain (LBD). The lat-
ter is not contiguous in sequence, its two segments S1 and S2 are 
interrupted by the pore region that is comprised of TMDs A and 
B and the pore loop between them. The LBD binds the agonist 
and undergoes a conformational change that is relayed to the pore 
region, ultimately leading to channel opening. The third TMD, 
TMD C, is linked to the intracellularly located C-terminal domain 
(CTD). The CTD is highly variable among the glutamate receptors, 
both in size and in sequence, and is subject to alternative splicing. It 
has a pivotal role in trafficking, membrane localization, and interac-
tion with cytoskeletal proteins (Sheng and Lee, 2001; Collingridge 
et al., 2004). In contrast to the CTD, the role and function of the 
TMD C remain unclear. In GluN2 subunits, several amino acids 
residing in TMD C appear to be involved in receptor desensitiza-
tion and in receptor modulation by ethanol (Ren et al., 2003a,b). 
Additionally, an ER retention signal in GluN2B is masked by the 
TMD C of GluN1 to enable ER export (Horak et al., 2008). The 
functional role of the TMD C in AMPA receptors, however, has 
not been investigated up to now. We therefore conducted a series 
of experiments designed to elucidate the function of this domain 
IntroductIon
Glutamate is the most abundant excitatory neurotransmitter in 
the vertebrate CNS and plays key roles in synaptoplastic events 
like long-term potentiation and depression. The superfamily of 
ionotropic glutamate receptors (iGluRs) in mammals consists of 18 
members, and this diversity is even increased by alternative splicing, 
RNA editing, and posttranslational modifications (Sommer et al., 
1990; Hollmann and Heinemann, 1994; Rosenmund et al., 1998; 
Seeburg et al., 1998; Hollmann, 1999). The iGluRs are classified 
into four subfamilies distinguishable by function, sequence iden-
tity, and pharmacological properties: The α-amino-3-hydroxy-5-
methyl-4-isoxazole propionate (AMPA) receptors GluA1 to GluA4 
are the main mediators of fast synaptic transmission, whereas 
the N-methyl-d-aspartate (NMDA) receptors (GluN1, GluN2A 
through GluN2D, and GluN3A plus GluN3B) are silent under 
resting conditions; they become activated when the membrane is 
depolarized beyond −20 mV, e.g., by AMPA receptor activity. The 
kainate receptors GluK1 to GluK5 are located presynaptically as well 
as postsynaptically, and have been reported to operate in dual fash-
ion as both ionotropic and metabotropic receptors (Lerma, 2003; 
Rozas et al., 2003). The fourth subfamily of glutamate receptors 
comprises the “orphan” receptors GluD1 and GluD2; up to now, 
neither their physiological function nor their ligand(s) have been 
identified unequivocally. Please note that the new glutamate recep-
tor nomenclature recently recommended by IUPHAR (Collingridge 
et al., 2009) is used throughout.
All iGluRs share a common domain topology and quaternary 
structure (Figure 1A); in these characteristics, the iGluR super-
family differs greatly from other ligand-gated ion channels (LGICs) 
such as acetylcholine (ACh), γ-aminobutyric acid (GABA), or gly-
cine receptors. While these receptor complexes are comprised of 
five subunits with four transmembrane domains each, functional 
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as a whole as well as of single amino acids residing within it. In 
doing so, we exploited the modular design of iGluRs that allows for 
homologous domains to be interchanged between subunits from 
different subfamilies, conveying the properties of the donor domain 
to the accepting receptor. The feasibility of this domain-swapping 
approach has been shown before for other domains such as the 
pore region (Strutz-Seebohm et al., 2003; Hoffmann et al., 2006a,b; 
Tapken and Hollmann, 2008; Villmann et al., 2008) or the LBD 
(Schmid et al., 2009).
Two basic roles are conceivable for the TMD C in AMPA recep-
tors: On the one hand, it could constitute a simple membrane 
anchor. Since the CTD is extremely important for correct   trafficking 
and intracellular localization of the receptor (Hayashi et al., 2000), 
it needs to be located on the cytoplasmic side of the plasma mem-
brane, a position established and maintained by the TMD C. If 
membrane anchoring was indeed the key function of TMD C, 
the sequence of the domain should be of minor importance, as 
long as it forms a membrane-spanning alpha helix. On the other 
hand, it is easily imaginable that the domain is actively involved 
in receptor gating and desensitization, as has been proposed for 
NMDA receptors (Ren et al., 2003a,b; Jang et al., 2004). In this case, 
the transplantation of the TMD C from another iGluR subfamily 
into an AMPA receptor should alter the functional properties of 
the receptor. Furthermore, the TMD might also be involved in 
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FiguRe 1 | (A) Domain topology of ionotropic glutamate receptors. Other 
proteins homologous to the domains are given in brackets. The NTD shares 
homologies with the bacterial leucine binding protein (LBP) and leucine–
isoleucine–valine binding protein (LIVBP), as well as the LBD of metabotropic 
glutamate receptors (O’Hara et al., 1993). The LBD of iGluRs shares sequence 
similarities with the bacterial leucine–arginine–ornithine binding protein (LAOBP) 
(Kuryatov et al., 1994), and the pore region shows structural homology to the 
pore of potassium channels with an inverted orientation (Kuner et al., 2003). For 
the linker regions, the TMD C, and the CTD no homologous sequences have 
been identified. (B) Local sequence alignment of the TMD C regions of all iGluR 
subunits that were used as TMD C donors in domain transplantation constructs. 
Two residues, G790 and F792 are conserved among all 18 iGluR subunits. 
Residues that were altered in this study are indicated by asterisks. (C) Helical 
wheel representation of the TMD C of GluA1. Residues investigated in this study 
are encircled in red. Numbering refers to the mature GluA1 sequence, without 
the signal peptide.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  3
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A  followed  by  streptavidin–agarose-mediated  precipitation  of 
glycosylated surface proteins. Crude protein mixtures were sepa-
rated by SDS–PAGE and blotted onto HyBond ECL-nitrocellulose 
membranes (GE Healthcare, Chalfont St. Giles, UK) as described 
previously (Villmann et al., 1999). The detection of proteins was 
performed using a primary antibody (diluted 1:1000 in TBS) 
directed against the C-terminus of GluA1 (kind gift from R.L. 
Huganir,  Johns  Hopkins  University  of  Medicine,  Baltimore, 
MD, USA). Horseradish peroxidase-labeled mouse anti-rabbit 
IgG (Pierce poly-HRP, Fisher Thermo Scientific, Waltham, MA, 
USA)  was  used  as  secondary  antibody  (dilution  1:20,000  in 
TBS). Immunoreactive bands were visualized using the Pierce 
SuperSignal pico or SuperSignal femto ECL kits (Fisher Thermo 
Scientific, Waltham, MA, USA).
Western blots were quantified using the software ImageJ, inten-
sity values were normalized to the wild type band in each blot.
StatIStIcal analySeS
To  ensure  comparability  between  different  oocyte  batches,  all 
recorded currents were normalized batch-wise. Agonist-induced 
currents of GluA1 wild type were averaged for each batch; subse-
quently, all recorded currents from that batch were normalized to 
this average. Significances were calculated using either an unpaired, 
two-tailed t-test or a one-way ANOVA with Dunnett’s post test. 
Statistical analyses were performed using Prism 5.0 (GraphPad 
Software, San Diego, CA, USA).
Structure analySIS
Analysis of the GluA2 crystal structure (PDB# 3KG2, Sobolevsky 
et al., 2009) was performed using PyMOL (DeLano Scientific, San 
Francisco, CA, USA).
reSultS
the Sequence of the tMd c of Glua1 IS crucIal for receptor 
functIon, but not for aSSeMbly and MeMbrane InteGratIon
The initial question was whether the TMD C constitutes a solely 
structural domain that simply serves a scaffolding function, or 
whether its amino acids are involved in specific aspects of recep-
tor function. To test this, constructs were generated in which the 
TMD C of GluA1 was replaced by the sequence of TMD A from 
the same receptor, resulting in an A-B-A TMD topology.
When heterologously expressed in Xenopus oocytes, the con-
struct did not yield functional ion channels. Upon application 
of 300 μM glutamate or 150 μM kainate, no currents could be 
detected (data not shown). This outcome was unaffected by the 
coexpression of the TARP γ2, which increases both glutamate and 
kainate-evoked currents of wild type GluA1 by at least one order 
of magnitude. Western blot analysis of plasma membrane sur-
face proteins, however, revealed that GluA1(A-B-A) was inserted 
into the membrane in the absence and presence of γ2 (Figure 2). 
Replacement of the TMD C by the TMD A sequence resulted in an 
altered electrophoretic mobility of the protein. A shortening of the 
protein as a result of the domain exchange can be ruled out, since 
the antibody used for detection binds to the CTD of the receptor. A 
chain termination in the TMD C region hence would have caused 
the signal to disappear. It has long been known that the apparent 
molecular weight of a peptide can vary from the theoretical weight 
  interactions with the transmembrane AMPA receptor regulatory 
protein (TARP) family of proteins, though no evidence for this has 
been reported to date. As depicted in Figure 1B, the amino acid 
sequence of the TMD C is highly conserved within the subfamilies, 
whereas it is only moderately conserved between them. There are, 
however, two residues, G790 and F792, which are conserved among 
all 18 iGluR subunits. The helical wheel representation (Figure 1C) 
shows that these two residues are located on opposing sides of 
the helix. Please note that numbering throughout the article refers 
to the amino acid positions in the sequence of putatively mature 
GluA1, without the signal peptide.
MaterIalS and MethodS
Molecular bIoloGy
All constructs were generated by PCR-directed mutagenesis using 
oligonucleotides  bearing  the  desired  mutations  (Microsynth, 
Balgach, Switzerland). Domain borders were defined based on the 
Swiss-Prot entries for the respective subunits from Rattus norvegi-
cus (Accession numbers: GluA1: P19490; GluA2: P19491; GluA3: 
P19492; GluK2: P42460; GluN1: P35439; GluN2A: Q00959; GluD1: 
Q62640). All chimeras and point mutants were inserted into the 
Xenopus oocyte expression vector pSGEM.
crna SyntheSIS
cDNA was transcribed using the mMESSAGE mMACHINE Kit 
(Ambion, Austin, TX, USA) according to the protocol provided. 
RNA integrity was checked via denaturing agarose gel electrophore-
sis. RNA concentration was determined photometrically using a 
NanoPhotometer (Implen GmbH, Munich, Germany).
heteroloGouS expreSSIon In Xenopus oocyteS
Stage V or VI oocytes were surgically removed from the ovaries of 
anesthetized Xenopus laevis and prepared as described previously 
(Schmidt et al., 2006). For homomeric expression of mutants, 8 ng 
(40 nl) of cRNA were injected within 24 h after surgery. For coex-
pression with the TARP γ2, 8 ng (40 nl) receptor cRNA and 0.8 ng 
(40 nl) TARP cRNA were mixed and coinjected. Electrophysiological 
recordings were carried out 4–5 days after injection. Two electrode 
voltage clamping was performed using a TurboTec-10CX ampli-
fier (NPI electronic, Tamm, Germany) controlled by Pulse soft-
ware (HEKA Elektronik, Lambrecht, Germany). Borosilicate glass 
capillaries were pulled to resistances of 1–3 MΩ and filled with 
3 M KCl (potential electrode) or 3 M CsCl (current electrode). 
Oocytes were clamped at −70 mV and continuously perfused with 
calcium-free Ringer’s solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM 
MgCl2, 10 mM HEPES–NaOH, pH 7.2) to avoid artifacts evoked 
by endogenous Ca2+-gated chloride channels. The agonists gluta-
mate (Sigma, Taufkirchen, Germany) and kainate (Ascent Scientific, 
Bristol, UK) and glutamate in combination with trichlormethiazide 
(TCM) (Sigma) were applied for 20 s.
labelInG of cell-Surface proteIn, WeStern blottInG, and 
quantIfIcatIon
Oocytes were used for plasma membrane-resident protein analy-
sis 5 days after cRNA injection following a previously described 
protocol (Hollmann et al., 1994). Isolation of surface membrane 
proteins was achieved by labeling with biotinylated concanavalin Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  4
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generated in which the TMD C of GluA1 was replaced by that 
of either GluA2, GluA3, GluK1, GluK2, GluK3, GluK4, GluN1, 
GluN2A, or GluD1. The chimeras were heterologously expressed in 
Xenopus oocytes, and agonist-evoked currents were recorded. Since 
GluA1 readily forms homomeric receptors in oocytes, the chimeric 
constructs could be expressed without additional subunits.
When expressed in the absence of a TARP, the chimeras GluA1-
(TMDC)GluA2,  GluA1-(TMDC)GluA3,  and  GluA1-(TMDC)
GluK1 yielded currents that were significantly larger in amplitude 
than  background  currents  seen  in  uninjected  control  oocytes 
(Figure  3A).  GluA1-(TMDC)GluK2  produced  kainate-evoked 
currents corresponding to 25% of the wild type, which correlates 
with reduced protein expression (Figure 3B). When the TARP γ2 
was coexpressed in order to boost GluR expression, nearly all con-
structs produced distinct current responses significantly different 
from controls upon application of kainate (Figure 3A, Table 1). 
Exceptions  were  the  chimeras  GluA1-(TMDC)GluN1,  GluA1-
(TMDC)GluN2A, and GluA1-(TMDC)GluD1. Although the lat-
ter did not reach significance levels, kainate-induced currents still 
amounted to 23% of wild type currents. In contrast, the replace-
ment of the TMD C of GluA1 by that of GluN1 or GluN2A caused 
a nearly complete loss of function. Western blot analysis revealed 
(Dunker and Rueckert, 1969) and that the exchange of single amino 
acid residues can cause shifts in mobility up to several kDa (Fasano 
et al., 1984; Armstrong and Roman, 1992).
the tMd c of Glua1 can be replaced by the hoMoloGouS 
doMaInS froM other iGlur faMIlIeS WIthout loSInG 
functIonalIty
The next set of constructs was made to clarify whether domain 
transplantation between iGluR subunits is possible for the TMD 
C as it is for other domains. To this end, chimeric receptors were 
WT ABA Ctrl
-2 γ +2 γ
WT ABA Ctrl
130 kDa
100 kDa
FiguRe 2 | Membrane expression analysis of gluA1 wild type (WT) and 
gluA1(TMD)ABA in the absence and presence of γ2. Control lanes show 
preparations of oocytes injected with water or γ2.
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FiguRe 3 | (A) Kainate-induced current amplitudes of TMD C chimeras in the 
absence and presence of γ2. Currents were normalized to the wild type; error 
bars show the SEM. Asterisks represent significant differences to controls 
(uninjected or γ2-injected oocytes, respectively). **p > 0.01, ***p > 0.001, 
one-way ANOVA with Dunnett’s post test. (B) Western blot analysis of 
expression of the TMD C chimeras. All constructs are detectable in the 
membrane fraction, independently of TARP expression. However, GluA1(TMDC)
GluK2 is only weakly present in the absence of γ2, and GluA1(TMDC)GluN1 
exhibits band broadening. Ctrl, controls injected with water. (C) Densitometric 
quantification of the Western blots shown in (B). Since the membrane protein 
preparations were performed in three different batches of oocytes, band 
intensities were normalized to GluA1 wild type in absence of γ2 for each batch.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  5
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  glutamate-induced currents: Although absolute amplitudes are 
still increased compared to expression without γ2, the mutant is 
only boosted 20-fold, which is significantly lower than the 30-fold 
potentiation seen in the wild type (Figure 4C). As a result, cur-
rents elicited by glutamate only amount to 1.5% of the wild type 
amplitude in presence of the TARP (Figure 4A).
In wild type GluA1 the effect of γ2 on desensitization out-
weighs the effect of TCM. Therefore, the TCM potentiation fac-
tor is lower for the wild type when the TARP is coexpressed. For 
GluA1-(TMDC)GluN1(M793Y) this masking effect by γ2 is com-
pletely lost. Potentiation by TCM is five-fold in both the absence 
and presence of γ2, which is a highly significant difference to the 
wild type (Figure 4B).
tWo hIGhly conServed aMIno acId reSIdueS In the tMd c of 
iGlurs are pIvotal for receptor functIonalIty
Local sequence alignment of TMD C amino acid residues shows 
that two residues, G790 and F792, are conserved among all 18 
known iGluR subunits (indicated for the subunits investigated in 
this study in Figure 1B). Since a high degree of conservation often 
indicates key roles for the respective residues in protein function, 
these two positions were exchanged for alanine in two independ-
ent constructs, GluA1(G790A) and GluA1(F792A). GluA1(G790A) 
gave stable current responses upon agonist application that cor-
responded to 56% of mean GluA1 wild type currents for kainate 
(Figures 5A,E, Table 3). Contrary to that, glutamate-elicited cur-
rents exhibited only 12% of the wild type amplitude. In combina-
tion with TCM, glutamate-evoked currents of 34% of the wild type 
amplitude were observed. Coexpression of γ2 caused an increase in 
all agonist-induced currents. Kainate-evoked currents were potenti-
ated about 10-fold by γ2 in both the wild type and GluA1(G790A); 
mean currents of the latter reached 54% of the wild type amplitude, 
which is indistinguishable from the 56% seen in the absence of γ2. 
However, the picture was completely different for glutamate-in-
duced currents: While responses of the wild type were only boosted 
roughly 20-fold by the TARP, GluA1(G790A) showed a 40-fold 
potentiation (Figure 5C). Mean amplitudes of the construct in 
the presence of a TARP corresponded to 27% of the wild type, 
which was significantly more than in the absence of γ2. The pres-
ence of TCM increased glutamate-elicited currents even stronger 
to nearly 80% of the wild type currents. Relative potentiation by 
TCM was increased for GluA1(G790A) in both the presence and 
the absence of γ2, yet in the latter case this increase was significantly 
higher, reaching a 10-fold potentiation (Figure 5B) compared to 
a   three-fold potentiation when γ2 is coexpressed. This means that 
in the absence of γ2 the mutant is potentiated stronger by TCM 
that the GluN2A chimera was properly delivered to the membrane, 
as was the GluD1 chimera, whereas GluA1-(TMDC)GluN1 exhib-
ited a broadened band on the Western blot (Figure 3B). However, 
densitometric quantification (Figure 3C) showed that the total 
amount of protein in the lane equaled that of the wild type.
a SInGle aMIno acId exchanGe IS SuffIcIent to reStore 
receptor functIonalIty In a non-functIonal tMd c chIMera
Sequence comparison reveals that the TMD C of GluN1 differs in 
14 out of 21 amino acid residues from that of GluA1. However, only 
four of these residues are exclusive to GluN1 and are not found at 
the corresponding positions in the TMD C of any other glutamate 
receptor subunit. Hence, three constructs were made in which the 
residues M793, G802, and F807 in the chimera GluA1-(TMDC)
GluN1 were replaced by the respective residues found in GluA1. 
Analysis of the fourth residue, L794, was omitted since its mutation 
would have constituted a leucine to isoleucine exchange that was 
considered, in all likelihood, to be of minor impact. When expressed 
in oocytes, all constructs were delivered to the membrane at levels 
much higher than the initial chimera GluA1-(TMDC)GluN1, as 
shown by Western blot analysis (Figure 4D).
Despite the high expression levels, constructs GluA1-(TMDC-)
GluN1(G802A)  and  GluA1-(TMDC)GluN1(F807L)  gave  no 
observable  currents  upon  application  of  glutamate  or  kainate 
(data not shown). The third construct, however, GluA1-(TMDC)
GluN1(M793Y), turned out to be a regain-of-function mutation. 
Upon application of both glutamate and kainate, this construct 
reproducibly showed currents that were stable, although signifi-
cantly reduced, reaching 3.2% of mean GluA1 wild type currents in 
the case of glutamate and 4.6% in the case of kainate (Figures 4A,E, 
Table 2). The addition of the AMPA receptor-specific desensitiza-
tion inhibitor TCM led to a slight relative increase in the glutamate-
induced current amplitude, corresponding to 4% of GluA1 wild 
type currents. Yet, the potentiation by TCM was not significantly 
altered compared to GluA1 wild type (Figure 4B); GluA1-(TMDC)
GluN1(M793Y) is potentiated five-fold by TCM, the wild type   
3.8-fold.
The  coexpression  of  the  TARP  γ2  causes  potentiation  of 
  agonist-evoked currents by multiple mechanisms; in addition to 
elevated expression levels, glutamate-induced steady-state currents 
are increased due to decreased desensitization, whereas kainate-
evoked currents are augmented because of an increased kainate 
efficacy (Priel et al., 2005; Turetsky et al., 2005). For the mutant 
GluA1-(TMDC)GluN1(M793Y) the latter effect is clearly pro-
nounced, kainate-induced currents reach 32% of the wild type 
amplitude. Contrary to this, the picture is completely different for 
Table 1 | Normalized kainate-induced currents of all generated chimeras in presence and absence of the TARP γ2, all values in % ± SeM.
gluA1(TMDC)  wt  A2  A3  K1  K2  K3  K4  N1  N2A  D1  Ctrl
−γ2  100 ± 18  170 ± 20  212 ± 27  112 ± 27  24.5 ± 5.0  67.5 ± 0.4  2.3 ± 0.4  1.0 ± 0.4  0 ± 0  0.8 ± 0.2  0.8 ±0.3 
  n = 14  n = 6  n = 5  n = 6  n = 5  n = 5  n = 6  n = 11  n = 12  n = 8  n = 4 
+γ2  100 ± 7.8  73.1 ± 15  123 ± 6.4  66.3 ± 6.0  48.6 ± 4.5  47.6 ± 2.0  36.5 ± 3.8  0 ± 0  1.2 ± 0.3  22.7 ± 0.4  0 ± 0 
  n = 10  n = 6  n = 5  n = 6  n = 6  n = 5  n = 5  n = 9  n = 12  n = 8  n = 5
Currents were recorded in three batches of oocytes and normalized to the wild type for each batch. Mean wild type current amplitudes were 82.1, 149, and 569 nA, 
respectively. Control oocytes were injected with water or γ2.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  6
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FiguRe 4 | (A) Mean agonist-induced current amplitudes of the construct 
GluA1-(TMDC)GluN1(M793Y) in absence and presence of γ2. (B) Potentiation 
of glutamate-evoked currents by TCM, a desensitization inhibitor. (C) 
Potentiation of glutamate-induced currents by γ2. Levels of significance were 
calculated by unpaired, two-tailed t-tests. (D) Membrane expression of point 
mutants of the GluN1 chimera. All mutants are expressed and integrated into 
the plasma membrane at higher levels than the initial chimera GluA1-(TMDC)
GluN1. (e) Exemplary current traces of GluA1 wild type and GluA1-(TMDC)
GluN1(M793Y). Glutamate-induced currents are shown in the top row, 
glutamate-induced currents in presence of TCM are shown in the top row, 
and kainate-evoked currents in the bottom row; currents recorded in the 
absence of the TARP γ2 are shown in the left half of the figure, currents 
observed in its presence in the right half. Please note different scaling 
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(Chen et al., 2000). All kainate receptor chimeras (containing TMD 
Cs of GluK1–GluK4) as well as the GluD1 TMD C chimera show 
currents between 23% (GluA1-(TMDC)GluD1) and 66% (GluA1-
(TMDC)GluK1) of the wild type amplitude when coexpressed with 
γ2. Analysis of membrane expression shows that this decrease can 
partly be attributed to a decrease in receptor protein expression. 
The chimeras carrying the TMD C of the NMDA receptor subu-
nits GluN1 and GluN2A exhibit a complete loss of function for 
the GluN1 construct, and show only very small currents for the 
GluN2A mutant. In the case of GluA1-(TMDC)GluN1 this is in 
part reflected by a reduction in membrane expression, while for 
GluA1-(TMDC)GluN2A it is not. This means that receptor func-
tion is critically dependent on amino acid residues located in the 
TMD C.
a SInGle aMIno acId exchanGe partIally reScueS a loSS-of-
functIon Mutant and SIMultaneouSly alterS ModulatIon 
by γ2
Replacement of a methionine residue at position 793 of the chi-
mera GluA1-(TMDC)GluN1 by tyrosine, the amino acid found 
in wild type GluA1, led to a partial restoration of receptor func-
tion. Similar to the chimeras discussed in the preceding section, 
the amplitude of kainate-induced currents of GluA1-(TMDC)
GluN1(M793Y) was dependent on the coexpression of γ2. When 
the TARP was present, kainate-evoked currents reached more 
than 30% of the wild type amplitude. Strikingly, the exact oppo-
site was observed for currents elicited by glutamate. Although γ2 
still boosted absolute glutamate-induced current amplitudes, the 
potentiating effect of γ2, which is due to decreased desensitiza-
tion, was significantly weaker. While glutamate-elicited currents 
reached 3% of GluA1 wild type amplitudes in the absence of γ2, 
they only exhibited a mere 1.5% of the wild type current when 
the TARP was coexpressed.
In wild type GluA1, the interaction with TARPs typically 
results in up to six-fold reduced desensitization, a mechanism 
that is independent of the simultaneous alteration of kainate effi-
cacy, with both mechanisms contributing to the observed larger 
steady state currents (Priel et al., 2005; Turetsky et al., 2005). The 
data presented here suggest that the reduction of desensitization 
by γ2 is absent in GluA1-(TMDC)GluN1(M793Y). The residual 
increase in absolute steady-state currents can be attributed to 
elevated surface expression facilitated by γ2, an effect that is inde-
pendent of the   pharmacological effects of the TARP. In line with 
than is the wild type. In presence of the TARP the effect of TCM is 
partially masked as explained previously. However, although this 
masking effect can be seen in the mutant, it is less pronounced than 
in the wild type. This indicates that the effects on desensitization 
by TCM and γ2 are mechanistically distinct, and that the influence 
of the G790A exchange on desensitization kinetics is independent 
of the open-state stabilization by γ2 and TCM.
The  second  construct  generated,  GluA1(F792A),  scarcely 
showed any detectable current responses upon agonist applica-
tion, irrespective of γ2 expression. Only in the absence of the TARP, 
kainate-induced currents corresponding to 5.8% of the mean wild 
type amplitude could be detected. In all other cases the observed 
relative currents did not exceed 1% of the wild type amplitude (data 
not shown). However, analysis of surface membrane expression 
revealed that GluA1(F807L) was present in the plasma membrane 
at even higher levels than the wild type. This was in sharp contrast 
to GluA1(G790A), the expression level of which closely resembled 
those of GluA1 wild type (Figure 5D).
dIScuSSIon
the tMd c of aMpa receptorS can be replaced by functIonally 
hoMoloGouS doMaInS, but not by Merely Structurally 
SIMIlar oneS
The initial experiments with an internally exchanged TMD show 
that the TMD C cannot be replaced by a merely structurally similar 
TMD without losing receptor function. However, while being non-
functional, the A-B-A mutant was expressed in the oocyte plasma 
membrane, indicating that changes in the TMD C have not much 
impact on proper membrane integration. However, the A-B-A con-
struct could only be detected when the TARP γ2 was coexpressed. 
Since TARPs have been shown to act as chaperones (Vandenberghe 
et al., 2005), it is conceivable that this TARP effect is necessary for 
the mutant to be inserted into the membrane correctly.
When the TMD C of GluA1 was replaced by a TMD C of other 
iGluRs, receptor function was retained in most cases, at least par-
tially. Perhaps not surprisingly, any functional impact of TMD C 
transplantation was least pronounced for constructs carrying the 
sequence of other AMPA receptors, which only differ in one amino 
acid in the case of GluA2 and two residues in the cases of GluA3 
and GluA4. For the other constructs, the amplitude of currents 
elicited by kainate was strongly dependent on the coexpression 
of γ2, which is known to enhance kainate efficacy (Turetsky et al., 
2005) and increase membrane expression levels of AMPA   receptors 
Table 2 | Absolute and normalized mean currents of gluA1 wild type and gluA1-(TMDC)gluN1(M793Y), in the absence and presence of the TARP γ2.
  Absolute currents ± SeM (nA)  Normalized currents ± SeM (%)
    n   300 μM glu  300 μM  150 μM KA  300 μM glu  300 μM  150 μM KA 
        glu + 600 μM TCM      glu + 600 μM TCM
GluA1  −γ2  5  104 ± 30  361 ± 79  404 ± 60  100 ± 29  100 ± 22  100 ± 15
  +γ2  9  3333 ± 500  4810 ± 638  19696 ± 1174  100 ± 15  100 ± 13  100 ± 6.0
GluA1-(TMDC)  −γ2  7  3.3 ± 0.9  14.4 ± 3.5  18.6 ± 5.5  3.2 ± 0.8  4.0 ± 1.0  4.6 ± 1.4 
GluN1(M793Y)
  +γ2  10  50.8 ± 7.8  265 ± 43  6413 ± 652  1.5 ± 0.2  5.5 ± 0.9  32.6 ± 3.3
Glu, glutamate; KA, kainate; TCM, trichlormethiazide.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  8
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FiguRe 5 | (A) Mean agonist-induced current amplitudes of the point mutant 
GluA1(G790A) in the absence and presence of γ2. (B) Potentiation of 
glutamate-evoked currents by TCM, a desensitization inhibitor. (C) Potentiation 
of glutamate-induced currents by γ2. (D) Membrane expression of point 
mutants of GluA1 wild type. (e) Exemplary current traces of GluA1 wild type 
and GluA1(G790A). Glutamate-induced currents are shown in the top row, 
glutamate-induced currents in presence of TCM are shown in the top row, and 
kainate-evoked currents in the bottom row; currents recorded in the absence of 
the TARP γ2 are shown in the left half of the figure, currents observed in its 
presence in the right half. Please note different scaling and units.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  9
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a GlycIne reSIdue conServed aMonG all iGlurs IS Involved In 
deSenSItIzatIon of aMpa receptorS
Replacing G790 of GluA1 with alanine causes functional impair-
ment of the receptor, as all agonist-induced current responses are 
decreased,  whereas  membrane  expression  levels  are  unaltered. 
Interestingly, currents evoked by different agonists are differen-
tially affected by the point mutation. While currents elicited by 
kainate in GluA1(G790A) in the absence of γ2 amount to 56% 
of wild type currents, glutamate evokes much smaller currents of 
only about 12%. This is counteracted by TCM, which increases 
glutamate-induced current amplitudes to 34% of the wild type. 
Coexpression of γ2 does not significantly alter relative kainate-
induced currents, but increases glutamate-elicited currents to 27% 
of the wild type amplitude. Taken together, these data indicate faster 
desensitization of the G790A mutant. Mechanistically, there are two 
possible ways of speeding up desensitization that might contribute 
to the observed effect. On the one hand, it is conceivable that the 
open state of the receptor is destabilized by the point mutation; 
this would, however, be rather surprising, since stabilization of the 
open state usually occurs in the LBD (Sun et al., 2002). Also, if that 
that is a significant change in TCM potentiation of this mutant: 
For the wild type, the TCM-mediated stabilization of the open 
state is less pronounced when γ2 is coexpressed, since the TARP 
itself stabilizes the receptor in the open conformation, thereby 
partially masking the effect of desensitization inhibitors such as 
TCM or cyclothiazide (Priel et al., 2005; Kott et al., 2007). For 
the GluA1-(TMDC)GluN1(M793Y) construct, however, TCM 
potentiation is unchanged by coexpression of γ2; it is actually 
indistinguishable from the potentiation seen in GluA1 wild type 
in the absence of γ2. Since kainate-induced currents are still 
boosted by γ2, this strongly suggests a specific interaction of γ2 
with this region of the TMD C, which thus is potentially involved 
in the mediation of desensitization-modulating interactions with 
the TARP. In the recently published crystal structure of GluR2 
(Sobolevsky et al., 2009) the TMD C is located on the outer 
surface of the receptor complex (Figure 6). The tyrosine residue 
corresponding to Y793 in GluA1 protrudes into the lipid bilayer, 
thus making an interaction of this domain with a membrane-
spanning auxiliary protein conceivable. However, this needs to 
be proven experimentally.
Table 3 | Absolute and normalized mean currents of gluA1 wild type and gluA1(g790A), in the absence and presence of the TARP γ2.
  Absolute currents ± SeM (nA)  Normalized currents ± SeM (%)
    n   300 μM glu  300 μM  150 μM KA  300 μM glu  300 μM  150 μM KA 
        glu + 600 μM TCM      glu + 600 μM TCM
GluA1  −γ2  5  271 ± 77  886 ± 254  1315 ± 246  100 ± 28  100 ± 22  100 ± 15
  +γ2  5  4758 ± 1309  5467 ± 476  14210 ± 950  100 ± 27  100 ± 13  100 ± 6.0
GluA1(G790A)  −γ2  5  32.8 (± 2.6)  304 ± 38  739 ± 163  12.1 ± 0.9  34.4 ± 4.2  56.1 ± 12
  +γ2  5  1316 ± 138  4260 ± 458  7666 ± 757  27.7 ± 2.9  77.9 ± 8.4  53.9 ± 5.3
Glu, glutamate; KA, kainate; TCM, trichlormethiazide.
C B A
FiguRe 6 | Localization of the residues discussed here in the crystal 
structure of gluA2 (PDB# 3Kg2), with residue numbering, however, 
referring to the respective positions in gluA1. (A) Side view; (B) Top view; 
shown are the TMDs and the pore loop of two subunits of the tetramer as 
indicated by numbers in brackets; the TMD C of the second subunit was 
omitted for clarity. Side chains of residues investigated in this study are 
indicated. The tyrosine residue at position 793 is oriented away from the pore, 
facing the lipid bilayer. (C) Detailed top view; the phenylalanine residue at 
position 792 is oriented toward the pore and is in close proximity to C524 in 
TMD A and to F604 in TMD B of the neighboring subunit, suggesting an 
interaction between those residues and explaining the loss of function evoked 
by an exchange of F792 to alanine.Frontiers in Molecular Neuroscience  www.frontiersin.org  December 2010  | Volume 3  | Article 117  |  10
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acid residues located near the extracellular boundary of the TMD 
C are crucial for receptor function. The exchange of highly con-
served residues either completely abolishes ion channel function 
(F792A) or greatly impairs it (G790A). For the latter mutant we 
could show that this particular glycine residue is of importance for 
receptor desensitization and hypothesize that this may be due to 
faster or more efficient relay to the membrane spanning domains 
of the conformational change induced by desensitization. We fur-
thermore found that the mutation of a non-functional chimera, 
GluA1-(TMDC)GluN1, at a single position in the TMD C can rees-
tablish receptor function to some extent. Strikingly, in this mutant 
distinct TARP effects are not observed, supporting the possibility 
that the TMD C is involved in AMPA receptor – TARP interac-
tions, which up to now have been thought to be restricted to the 
intra- and extracellular domains of these two proteins. Additionally, 
this could explain, why and how the interaction with TARPs is 
restricted to AMPA receptors. Amino acid residues in the TMD 
C could be involved as “recognition sites” for the TARP. However, 
this remains speculative. In summary, we have established a new 
role for the TMD C, exceeding that of a mere structural element, 
but rather being an active participant in AMPA receptor function, 
modulation, and interaction with auxiliary subunits.
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was the case, currents evoked in the presence of TCM or γ2 should 
also be clearly reduced, which they are not. On the other hand, it is 
possible that the reduction of glutamate-induced currents is not the 
result of destabilization of the open state, but of a faster or more 
efficient transmission of the desensitization-inducing conforma-
tional change from the LBD to the TMDs. A possible explanation 
for the latter could be the nature of the exchanged amino acid 
residue; glycine residues are thought to be critically involved in 
interactions between transmembrane α-helices (Javadpour et al., 
1999). Furthermore, glycine adds flexibility to α-helices; hence the 
G790A mutation would render the TMD C more rigid. Admittedly, 
the homologous position in GluA2 (G792), as revealed by the crys-
tal structure, shows no residues of other TMDs in close proxim-
ity that would support an inter-domain interaction. It should be 
noted, however, that this crystal structure shows the receptor in 
the open state, so possible interactions of G792 in the closed state 
remain speculative.
For the loss-of-function mutant F792A an interpretation based 
on the crystal structure is more straightforward. The phenylalanine 
residue is in close proximity to both a cysteine residue in TMD 
A (3.6 Å) and a phenylalanine residue in TMD B (3.3 Å) of the 
neighboring subunit (Figure 6C). This suggests an interaction of 
F792 with at least one of those residues, which is lost when F792 is 
mutated to alanine. The lack of inter-subunit helix–helix interac-
tions could explain the gating inability of the F792A mutant.
concluSIonS
We here for the first time provide experimental evidence that 
the TMD C of AMPA receptors is involved in channel gating and 
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